Factbites
 Where results make sense
About us   |   Why use us?   |   Reviews   |   PR   |   Contact us  

Topic: Bernadine Healy


Related Topics

In the News (Wed 23 Dec 09)

  
  Human Gene Therapy   (Site not responding. Last check: 2007-11-01)
In December 1992 Dr. Bernadine Healy, then Director of the NIH, approved a compassionate use exemption from the regular review process, to allow a critically ill patient to receive gene therapy.
This circumvention of the regular approval process proved very controversial and set off a series of meetings aimed at creating procedures for dealing with expedited review of single patient protocols in the future (V, National Institutes of Health 1993).
The minutes of this important meeting of the RAC relate the story of Bernadine Healy's compassionate use exemption, and the subsequent turmoil caused within the RAC.
www.georgetown.edu /research/nrcbl/publications/scopenotes/sn24.htm   (9596 words)

  
 ScienceDaily.com DIA_2005   (Site not responding. Last check: 2007-11-01)
Bernadine Healy, MD, former president and CEO of the American Red Cross, director of NIH and currently an advisor on bioterrorism and weapons of mass destruction and preparedness to the White House, highlighted the major issues facing the pharmaceutical today during the Monday morning Keynote Address.
She began her address by stressing the need to restore public faith in the pharmaceutical industry.
Healy, the first woman to give the DIA Annual Meeting Keynote address, focused on drug pricing, recent high-profile drug withdrawals, conflicts of interests among scientists, even at NIH, and trusting what's in the medicine bottle.
sciencedaily.mediwire.com /main/default.aspx?P=DIA_2005   (599 words)

Try your search on: Qwika (all wikis)

Factbites
  About us   |   Why use us?   |   Reviews   |   Press   |   Contact us  
Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.